header
Government

Sushant Singh Rajput Case: Rhea Chakraborty Booked Under Narcotic Drugs Act

The NCB is now the third federal investigative agency probing the case apart from the ED and the CBI.

New Delhi: The Narcotics Control Bureau (NCB) on Wednesday registered an FIR against actor Rhea Chakraborty and some others under several sections of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

The move comes after the Enforcement Directorate (ED) – which is probing a money laundering angle into the death of actor Sushant Singh Rajput, and had questioned his girlfriend Chakraborty – referred some evidence to the CBI and the NCB about alleged links to banned drugs.

The NCB is now the third federal investigative agency probing the case apart from the ED and the CBI.

Chakraborty’s lawyer Satish Manehsinde has denied the charge. “Rhea has never consumed drugs in her life ever. She is ready for a blood test,” Maneshinde said.

Chakraborty, 28, has been grilled twice in this case by the ED and her statement recorded under the Prevention of Money Laundering Act (PMLA).

Also read: Rhea Chakraborty’s Trial by Media Reflects Entrenched Misogyny

The ED money laundering case stems from an FIR filed by Rajput’s father K.K. Singh on July 25 with the Bihar police in Patna, against Chakraborty, and members of her family as well as her managers, accusing them of cheating and abetting his son’s suicide.

In his complaint to the police, Rajput’s father had alleged that an amount of Rs 15 crore was siphoned off from his son’s bank account in one year to the accounts of persons not known or connected to the late actor.

Since then, Chakraborty has been hounded by the media with TV channels indulging in voyeuristic coverage and producing new theories by the day.